The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - To those following the story (and PropThink’s coverage), it should come as little surprise that Cornerstone Therapeutics’ (CRTX) majority shareholder Chiesi Farmaceutici SpA is making … Continue Reading
Read nowLong Ideas - Short interest in Raptor Pharmaceuticals (RPTP) increased by 6% over the last two months, in tandem with the stock’s rise to $6.28, which has since … Continue Reading
Read nowLong Ideas - PropThink’s first story of the week turned into a whopping 24% gainer by Friday’s close. We iterated our enthusiasm for Pharmacyclics (PCYC) on Monday, following … Continue Reading
Read nowMost Popular - Shares of ResMed Inc. (RMD) have finally found their top, peaking at $48.37 in late January before dropping to the $43 level. But the downslide … Continue Reading
Read nowLong Ideas - Shares of Life Technologies (LIFE), one of the world’s largest life science companies, have soared in just the first few weeks of 2013, rising over … Continue Reading
Read nowLong Ideas - A letter from Fresenius Medical (FMS) on Tuesday stated that the nation-wide dialysis provider would pause expansion of its pilot program utilizing Omontys, Affymax’s (AFFY) … Continue Reading
Read nowLong Ideas - Achillion Pharmaceuticals (ACHN) reported positive clinical trial results for ACH-3102, the company’s NS5A inhibitor for hepatitis C (HCV). Achillion remains a leading independent mid-stage biotech … Continue Reading
Read now
